Solution
SDOH-Powered Health Equity Analytics
Solution
SDOH-Powered Health Equity Analytics
Industry
Pharma & Life Sciences
Region
US
Technology
Databricks
Context
Pharma leaders face mounting challenges in addressing health disparities, such as fragmented SDOH data and insufficient diagnosis-level granularity, especially in oncology health disparities analysis. A robust health equity analytics solution bridges this gap, delivering tumor-specific and geographic health disparity insights. These scalable, SDOH-powered health equity analytics solutions empower commercial and marketing teams to expand brand uptake, optimize outreach, and advance equity objectives—driving both measurable market performance and improved patient outcomes.
Problem Statement
A leading global healthcare organization was facing significant limitations with their outsourced health equity analytics solution. The lack of SDOH data analytics and clarity on underserved populations led to inconsistencies in insight quality and alignment with strategic objectives, which hindered engagement and affected outcomes, especially in tracking geographic health disparity insights across the highest-need regions.
Impact
- Brand Opportunity: Analysis enabled brand-specific interventions in high-disparity geographies.
- Oncology Domain Insights Expansion: Advanced analysis included health equity and SDOH insights for tumor data.
- Geography Level Expansion: Solution extended to the County-level alongside ZIP and CBSA-level data.
- Scalable Architecture: Enhanced control over business rules with scalable architecture adaptable to new tumors/ regions